Mach-1 Financial Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,737
Closed -$555K 285
2023
Q3
$555K Buy
+12,737
New +$555K 0.23% 92